The Future of Asthma and COPD: Conference Highlights

The respiratory therapy area is witnessing groundbreaking advancements, particularly in the management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. These conditions affect millions globally and continue to drive significant research and development in the healthcare industry. Through conference coverage intelligence, stakeholders gain insights into the latest assets, pipeline developments, and innovative treatments being explored for these respiratory diseases. Asthma and COPD: A Growing Global Challenge Both asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic respiratory conditions that lead to a substantial burden on healthcare systems worldwide. Asthma primarily affects the airways, causing wheezing, shortness of breath, and coughing, while COPD, a progressive disease most often caused by smoking, leads to difficulty in breathing and can result in long-term disability. The global prevalence of these diseases is rising, particularly in aging populations...